Loading organizations...
Loading organizations...
Advanced biopharmaceutical company using adipose stem cells for therapies.
Novadip Biosciences has raised $77.2M across 3 funding rounds.
Novadip Biosciences has raised $77.2M in total across 3 funding rounds.
Novadip Biosciences has raised $77.2M in total across 3 funding rounds.
Novadip Biosciences's investors include Olivier van der Rest, Pierre Drion, CR-CP Life Science Fund, Fund+, InvestSud, SRIW, VIVES Louvain Technology Fund, Jason Zhou, Invest.BW, Franssen Christina, Epim 'e'de, Integral Venture Partners.
Novadip Biosciences has raised $77.2M across 3 funding rounds. Most recently, it raised $23.6M Series B in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 3, 2022 | $23.6M Series B | Olivier van der Rest, Pierre Drion, CR-CP Life Science Fund, Fund+, InvestSud, SRIW, VIVES Louvain Technology Fund | |
| Oct 28, 2021 | $22.1M Series B | Jason Zhou | Fund+, Invest.BW, InvestSud, Franssen Christina, VIVES Louvain Technology Fund |
| Sep 10, 2015 | $31.5M Series A | Epim 'e'de, Fund+, Integral Venture Partners, SFPI-FPIM, SRIW, Startup Capital Ventures, VIVES Louvain Technology Fund |